Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?

Summary

An open-label, multi-centre, 26-weeks clinical feasibility study. The objective is to explore whether Saxenda could be a feasible choice in the treatment of overweight, obesity and weight-related medical problems, in patients diagnosed with a severe mental illness and hospitalized at a forensic department in Denmark. We wish to determine the viability of the daily Saxenda®-injection treatment in this specific patient group.

Timeline

Start

2021-07-01

Primary completion

2022-07-21

Completion

2022-09-01

Drugs

Indications